ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

SILO Silo Pharma Inc

1,04
-0,06 (-5,45%)
17 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Silo Pharma Inc SILO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,06 -5,45% 1,04 20:52:05
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,15 1,04 1,15 1,0498 1,10
mais cotações »

Notícias Recentes

Data Hora Fonte Título
07/06/202409:18GLOBESilo Pharma Announces Successful Production of its SP-26..
06/06/202417:50GLOBESilo Pharma Announces Closing of $2 Million Registered..
05/06/202409:00GLOBESilo Pharma Announces $2 Million Registered Direct Offering..
04/06/202409:41GLOBESilo Pharma Submits Pre-Investigational New Drug Application..
21/05/202409:45GLOBESilo Pharma Announces Positive Results from Study for..
14/05/202409:45GLOBESilo Pharma to Participate in FDA Meeting Exploring Emerging..
23/04/202409:15GLOBESilo Pharma Announces Positive Results for Intranasal PTSD..
10/04/202409:11GLOBESilo Pharma set to Acquire Exclusive Licensing for Promising..
20/03/202409:30GLOBESilo Pharma Exercises Option for Exclusive License Agreement..
18/03/202408:15GLOBESilo Pharma Files Patent for Groundbreaking Ketamine Implant..
28/02/202410:25GLOBESilo Pharma Completes Successful Dose-Ranging Study of..
14/02/202410:45GLOBESilo Pharma’s SP-26 Ketamine Implant Demonstrates Successful..
01/02/202412:00GLOBESilo Pharma Announces Pipeline Prioritization for 2024..
24/01/202410:55GLOBESilo Pharma Announces Positive Results in Alzheimer’s..
04/01/202410:55GLOBESilo Pharma Successfully Completes First Phase of..
28/12/202310:25GLOBESilo Pharma and Partner Receive Regulatory Approval to Begin..
21/11/202310:01GLOBESilo Pharma Enters into Exclusive License Agreement with..
08/11/202310:11GLOBESilo Pharma to Initiate Dose-Ranging Study of Novel..
16/10/202309:11GLOBESilo Pharma’s SPU-21 Peptide Shows Positive Results Against..
11/10/202309:35GLOBESilo Pharma Initiates Human Factor Study of SPC-15 for the..
20/09/202309:28GLOBESilo Pharma Announces Positive Data on SPC-15 for PTSD and..
12/09/202309:50GLOBESilo Pharma Initiates Feasibility Study of SPC-15 Novel..
10/08/202309:50GLOBESilo Pharma Engages Clarivate for Intellectual Property and..
08/08/202309:30GLOBESilo Pharma Reaches Positive Milestone with Nasal..
21/06/202310:00GLOBESilo Pharma’s SPU-21 Treatment for Autoimmune Disease..

Seu Histórico Recente

Delayed Upgrade Clock